Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Epidermal Growth Factor Receptor Transactivation Is Regulated by Glucose in Vascular Smooth Muscle Cells*
Atsushi Konishi, and
Bradford C. Berk
Center for Cardiovascular Research, University of Rochester, Rochester,
New York 14642
Abstract:
We hypothesized that glucose-mediated alterations in vascularsmooth muscle
cell signal transduction contribute to diabeticcomplications. We found
enhanced AngII activation of Akt andextracellular ERK1/2 in vascular smooth
muscle cells incubatedwith high glucose (27.5 mM) compared with
low glucose (5.5mM). Because AngII-mediated transactivation of the
epidermalgrowth factor receptor (EGFR) is important in Akt and ERK1/2
activation, we studied the effects of glucose on EGFR function.The EGFR in
cells cultured for 48 h in low glucose was smaller(145 kDa) than the EGFR in
cells cultured with high glucose(170 kDa). The shift from the 170-kDa isoform
to the 145-kDaisoform was reversible and dependent upon glucose concentration
with EC50 1 mM. N-Glycosylation was
responsible because peptideN-glycosidase F treatment of isolated
170-kDa EGFR yieldeda single band at 145 kDa. Cell surface biotinylation
showedthat the 145-kDa EGFR was present on plasma membrane. AngIIand other
G-protein-coupled receptor ligands known to transactivateEGFR phosphorylated
the 170-kDa EGFR but not the 145-kDa EGFR,whereas EGF, heparin-binding
EGF-like growth factor, and transforminggrowth factor- phosphorylated
both receptors. Subcellular fractionationshowed that the 145-kDa receptor
localized to a different plasmamembrane domain than the 170-kDa receptor.
These results establisha novel mechanism by which glucose-dependent EGFR
N-glycosylationmodulates AngII signal transduction and suggest a
potentialmechanism for pathogenic effects of AngII in diabetic
vasculopathy.
Received for publication May 9, 2003.
Revision received June 15, 2003.
* The costs of publication of this article were defrayed in partby the
payment of page charges. This article must thereforebe hereby marked
"advertisement" in accordance with 18 U.S.C.Section 1734
solely to indicate this fact.
To whom correspondence should be addressed: Center for Cardiovascular
Research, University of Rochester, 601 Elmwood Ave., Box 679, Rochester, NY
14642. Tel.: 585-273-1946; Fax: 585-273-1497; E-mail:
bradford_berk{at}urmc.rochester.edu.
The editors suggest the following Related Resources on Science sites:
Reduction of the ST6 {beta}-Galactosamide {alpha}-2,6-Sialyltransferase 1 (ST6GAL1)-catalyzed Sialylation of Nectin-like Molecule 2/Cell Adhesion Molecule 1 and Enhancement of ErbB2/ErbB3 Signaling by MicroRNA-199a.
A. Minami, Y. Shimono, K. Mizutani, K. Nobutani, K. Momose, T. Azuma, and Y. Takai (2013)
J. Biol. Chem.
288, 11845-11853
|Abstract »|Full Text »|PDF »
A Novel Role for Epidermal Growth Factor Receptor Tyrosine Kinase and Its Downstream Endoplasmic Reticulum Stress in Cardiac Damage and Microvascular Dysfunction in Type 1 Diabetes Mellitus.
M. Galan, M. Kassan, S.-K. Choi, M. Partyka, M. Trebak, D. Henrion, and K. Matrougui (2012)
Hypertension
60, 71-80
|Abstract »|Full Text »|PDF »
HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
L. Uttarwar, F. Peng, D. Wu, S. Kumar, B. Gao, A. J. Ingram, and J. C. Krepinsky (2011)
Am J Physiol Renal Physiol
300, F921-F931
|Abstract »|Full Text »|PDF »
Thrombin Stimulation of Proteoglycan Synthesis in Vascular Smooth Muscle Is Mediated by Protease-activated Receptor-1 Transactivation of the Transforming Growth Factor {beta} Type I Receptor.
M. L. Burch, M. L. Ballinger, S. N. Y. Yang, R. Getachew, C. Itman, K. Loveland, N. Osman, and P. J. Little (2010)
J. Biol. Chem.
285, 26798-26805
|Abstract »|Full Text »|PDF »
EGFR-PLC{gamma}1 signaling mediates high glucose-induced PKC{beta}1-Akt activation and collagen I upregulation in mesangial cells.
D. Wu, F. Peng, B. Zhang, A. J. Ingram, D. J. Kelly, R. E. Gilbert, B. Gao, S. Kumar, and J. C. Krepinsky (2009)
Am J Physiol Renal Physiol
297, F822-F834
|Abstract »|Full Text »|PDF »
S. Belmadani, D. I. Palen, R. A. Gonzalez-Villalobos, H. A. Boulares, and K. Matrougui (2008)
Diabetes
57, 1629-1637
|Abstract »|Full Text »|PDF »
Gas6-Axl Receptor Signaling Is Regulated by Glucose in Vascular Smooth Muscle Cells.
M. E. Cavet, E. M. Smolock, O. H. Ozturk, C. World, J. Pang, A. Konishi, and B. C. Berk (2008)
Arterioscler Thromb Vasc Biol
28, 886-891
|Abstract »|Full Text »|PDF »
Evidence for Vasculoprotective Effects of ETB Receptors in Resistance Artery Remodeling in Diabetes.
K. Sachidanandam, V. Portik-Dobos, A. K. Harris, J. R. Hutchinson, E. Muller, M. H. Johnson, and A. Ergul (2007)
Diabetes
56, 2753-2758
|Abstract »|Full Text »|PDF »
Type 2 Diabetes Causes Remodeling of Cerebrovasculature via Differential Regulation of Matrix Metalloproteinases and Collagen Synthesis: Role of Endothelin-1.
A. K. Harris, J. R. Hutchinson, K. Sachidanandam, M. H. Johnson, A. M. Dorrance, D. W. Stepp, S. C. Fagan, and A. Ergul (2005)
Diabetes
54, 2638-2644
|Abstract »|Full Text »|PDF »
Angiotensin II-induced Akt activation is mediated by metabolites of arachidonic acid generated by CaMKII-stimulated Ca2+-dependent phospholipase A2.
F. Li and K. U. Malik (2005)
Am J Physiol Heart Circ Physiol
288, H2306-H2316
|Abstract »|Full Text »|PDF »
Angiotensin II: A Devious Activator of Mineralocorticoid Receptor-Dependent Gene Expression.
B. C. Blaxall, J. M. Miano, and B. C. Berk (2005)
Circ. Res.
96, 610-611
|Full Text »|PDF »
Hydrogen Peroxide Activates the Gas6-Axl Pathway in Vascular Smooth Muscle Cells.
A. Konishi, T. Aizawa, A. Mohan, V. A. Korshunov, and B. C. Berk (2004)
J. Biol. Chem.
279, 28766-28770
|Abstract »|Full Text »|PDF »